A huge thank you to our Scientific Committee, the PGT Taskforce and everyone who contributed to the success of UEG Week and the PGT Programme 2025! We also thank all abstract presenters for enriching the excellent scientific programme of UEG Week! #UEGWeek #UEGcommunity

UEG SciCom at #UEGWeek! A heartfelt thanks to all SciCom members and the UEG Office team, and especially to Julia Mayerle for her outstanding leadership and dedication over the past years 👏 The success of #UEGWeek2025 reflects the power of collaboration — the collective

Congratulations to our young researcher Konrad Lehr, on receiving the “Best Scientific Presentation Award” at the #EHMSG2025 in Rome for his presentation on “Microbiota in Twins”! An outstanding achievement from an excellent collaboration with @JKupcinskasLT Group!

An excellent start in the exciting field of #microbiota at #EHMSG2025 in Rome! Great opportunity to engage in both clinical and scientific exchange with colleagues and friends, and continued collaboration and discovery! #EHMSG #Hpylori #eurFMT

📢After almost 25 amazing years at Otto-von-Guericke University Magdeburg, it’s time for a new adventure! From October 1, 2025, I’ll be joining Friedrich-Alexander University #FAU as W3 Professor of Gastroenterology at the Medical Campus Upper Franconia in #Bayreuth. Excited to

#Cancer and #PhysicalExercise ✅Structured exercise program after adjuvant chemotherapy resulted in significantly longer disease-free survival and overall survival in CRC patients ❓Could an exercise program reduce the need for adjuvant chemotherapy in patients at "low risk"?

What is the difference between probiotics and live biotherapeutic products (LBPs)? #Probiotics: ✅Live microorganisms which when administered in adequate amounts confer a ✅health benefit on the host. Live Biotherapeutic Products (#LBPs): A biological product that: (1)

EAGEN (Europäische Gesellschaft für Gastroenterologie, Endoskopie und Ernährung) lädt herzlich zum #Webinar ein: 📢Thema: Aktuelles Management von Helicobacter pylori-Infektionen 27. Mai 2025 um 17:00 Uhr Sprache: Deutsch Registrierung 👇 https://t.co/Sr1GLn9JYQ

EAGEN (Europäische Gesellschaft für Gastroenterologie, Endoskopie und Ernährung) lädt in Zusammenarbeit mit Juvise Pharmaceuticals herzlich zu einem #Webinar ein: 📢Thema: Aktuelles Management von Helicobacter pylori-Infektionen 27. Mai 2025 um 17:00 Uhr Sprache: Deutsch

#LifeInPlastic Nanoplastics are accumulating in the human brain—and their levels are rising. Why—and what are the consequences? https://t.co/eCqcbK8WcT

Interested in scientific advances related to the #microbiota in the upper GI tract? Join the Sino-German Summer Workshop on Microbiota in Upper GI Tract and Disease 25-26 July 2025 Technical University of Munich & Virtual 👉 https://t.co/LY0bEvXihR

#Olaparib considered a valuable option in patients with BRCA-mutation ovarian cancer ❗️disappointing final Overall Survival results from SOLO3 trial 👉Very valuable data for molecular tumour boards #MolecularOncology #PrecisionMedicine https://t.co/ZDiEtpaZn8

Are you a basic scientist interested in pathogenesis in digestive diseases? Be part of the DDM Summit, a basic research initiative during the #UEGweek in October 2025! Share your research! Submit your abstract! https://t.co/U9Q4n1sAIJ @my_ueg @EAGEN_org @EurFmt

Does #endoscopy screening impact upper GI #cancer mortality? ✅YES (in high risk situations/areas) n= 234 635 participants (age ~52y) Deaths in #highrisk area Endoscopy: 480 vs. Controls: 545 Deaths in non-high risk area Endoscopy: 146 vs. Controls 149

When #ERCP is performed in patients with biliary stenosis treated with stents - the stents are removed, replaced and discarded, but... ✅ stents preserve bile and sloughed cells, including #microRNA, suggesting it as a potential biomarker for biliary tract disease. Our

https://t.co/wp97ijyl5u

#WhatsNew on Management of precancerous conditions and early neoplasia of the stomach #MAPS3 ✅Fully updated and revised multidisciplinary #Guideline! @ESGE_news @ehmsg @EAGEN_org 👉 https://t.co/J53XL6VGYy

#WhatsNewOnFMT #CDI ❓Real-world efficacy of FMT for 1 and 2 CDI 📜n=467 multicentre study from Denmark 56% severe CDI 36% antibiotic-refractory CDI 19 fulminant CDI ✅Overall cure rate 79% ✅90-day mortality: 10% https://t.co/Uh7RAJ6LuJ

#EAGENwebinar Immunotherapy in Digestive Cancers: Where are we today? 1 April 2025 17:30-18:45 CET Join 👇 https://t.co/TZY2ytuqtV

#EAGEN Postgraduate Course ▶️Dilemmas and Controversies in Digestive Diseases Nis, Serbia, 14-16th March 2025 👉Join us for a face-to-face meeting! https://t.co/oBwXBdlKyG